Abstract
Hypertension (HT) is a common and life threating health problem worldwide leading to stroke, heart attack and renal failure. It is characterized by elevated blood pressure forced heart load. Human interleukin-6 (IL-6) and C- reactive protein (CRP) are known to be involved in inflammatory processes. IL-6 gene is a polymorphic gene which −174 G/C is a common and −572 G/C is a rare polymorphisms identified in promoter region. Publications on IL-6 gene polymorphisms raised the question whether this gene polymorphisms lead to susceptibility to HT or not. To investigate the effects of IL-6 gene −174 G/C (rs 1800795) and −572 G/C (rs1800796) polymorphisms on plasma IL-6 and CRP levels and their associations with hypertension disease in Turkish population we analyzed −174 G/C and −572 G/C polymorphisms and plasma IL-6 and CRP levels in 111 healthy controls and 108 hypertension patients from Adıyaman, Turkey. We determined the genotypes using polymerase chain reaction-restriction fragment length polymorphism and analyzed plasma levels of IL-6 by ELISA and CRP by automated standard biochemical methods. We have found no statistically significant differences between IL-6 gene −174 G/C and −572 G/C genotypes and allelic frequencies and IL-6 and CRP plasma levels and HT (p > 0.05). No CC genotype was found in control subjects for −572 G/C polymorphism. In conclusion, we found relation to −174 G/C and −572 G/C gene variants between neither IL-6 and CRP levels nor hypertension. The −572 G allele and GG genotype are predominant in Turkish population in Adıyaman, Turkey whereas the CC genotype is very rare.
Similar content being viewed by others
References
Baumann H, Gauldie J (1994) The acute phase response. Immunol Today 15:74–80
Bautista LE, Vera LM, Arenas IA, Gamarra G (2005) Independent association between inflammatory markers (C-reactive protein, interleukin-6, and TNF-a) and essential hypertension. J Hum Hypertens 19:49–154
Berg KK, Madsen HO, Garred P, Wiseth R, Gunnes S, Videm V (2009) The additive contribution from inflammatory genetic markers on the severity of cardiovascular disease. Scand J Immunol 69:36–42
Bermudez EA, Rifai N, Buring J, Manson JAE, Ridker PM (2002) Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22:1668–1673
Boos CJ, Lip GYH (2006) Is hypertension an inflammatory process? Curr Pharm Des 12:1623–1635
Chae CU, Lee RT, Rifai N, Ridker PM (2001) Blood pressure and inflammation in apparently healthy men. Hypertension 38:399–403
Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ; National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee (2003) The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA 289:2560–2572
Conen D, Cheng S, Steiner LL, Buring JE, Ridker PM, Zee RYL (2009) Association of 77 polymorphisms in 52 candidate genes with blood pressure progression and incident hypertension: the women’s genome health study. J Hypertens 27:476–483
Fishman D, Faulds G, Jeffery R, Mohamed-Ali V, Yudkin JS, Humphries S, Woo P (1998) The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis. J Clin Invest 102:1369–1376
Gao SP, Pan M, Chen C, Ge LJ, Jiang MH, Luan H, Zheng JG, Deng XT, Pan HY, Zhu JH (2011) The G to A polymorphism at -597 of the interleukin-6 gene is extremely rare in southern Han Chinese. Cytokine 55:1–3
Grundy SM, Benjamin IJ, Burke GL, Chait A, Eckel RH, Howard BV, Mitch W, Smith SC, Sowers JR (1999) Diabetes and cardiovascular disease a statement for healthcare professionals from the American Heart Association. Circulation 100:1134–1146
Humphries SE, Luong LA, Ogg MS, Hawe E, Miller GJ (2001) The interleukin-6 -174 G/C promoter polymorphism is associated with risk of coronary heart disease and systolic blood pressure in healthy men. Eur Heart J 22:2243–2252
Illig T, Bongardt F, Schöpfer A, Müller-Scholze S, Rathmann W, Koenig W, Thorand B, Vollmert C, Holle R, Kolb H, Herder C; Kooperative Gesundheitsforschung im Raum Augsburg/Cooperative Research in the Region of Augsburg (2004) Significant association of the interleukin-6 gene polymorphisms C-174G and A-598G with type 2 diabetes. J Clin Endocrinol Metab 89:5053–5058
Jenny NC, Tracy RP, Ogg MS, Luong LA, Kuller LH, Arnold AM, Sharrett AR, Humphries SE (2002) Interleukin-6 plasma levels and the -174G>C polymorphism are associated with the development of cardiovascular disease. Arterioscler Thromb Vasc Biol 22:2066–2071
Johansson BB (1999) Hypertension mechanisms causing strok. Clin Exp Pharmacol Physiol 26:563–565
Karahan ZC, Deda G, Sipahi T, Elhan AH, Akar N (2005) TNF-A-308G/A and IL-6 -174 G/C polymorphisms in the Turkish pediatric stroke patients. Thromb Res 115:393–398
Kearneya PM, Whelton M, Reynolds K, Whelton PK, He J (2004) Worldwide prevalence of hypertension: a systematic review. J Hypertens 22:11–19
Kitamura A, Hasegawa G, Obayashi H, Kamiuchi K, Ishii M, Yano M, Tanaka T, Yamaguchi M, Shigeta H, Ogata M, Nakamura N, Yoshikawa T (2002) Interleukin-6 polymorphism (-634C/G) in the promotor region and the progression of diabetic nephropathy in type 2 diabetes. Diabet Med 19:1000–1005
Li JJ, Fang CH, Hui RT (2005) Is hypertension an inflammatory disease? Med Hypotheses 64:236–240
Losito A, Kalıdas K, Santoni S, Jeffery S (2003) Association of interleukin-6 -174 G/C promoter polymorphism with hypertension and left ventricular hypertrophy in dialysis patients. Kidney Int 64:616–622
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, Heagerty AM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, Struijker Boudier HA, Zanchetti A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Filippatos G, Funck-Brentano C, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Zamorano JL, Kjeldsen SE, Erdine S, Narkiewicz K, Kiowski W, Agabiti-Rosei E, Ambrosioni E, Cifkova R, Dominiczak A, Fagard R, Heagerty AM, Laurent S, Lindholm LH, Mancia G, Manolis A, Nilsson PM, Redon J, Schmieder RE, Struijker-Boudier HA, Viigimaa M, Filippatos G, Adamopoulos S, Agabiti-Rosei E, Ambrosioni E, Bertomeu V, Clement D, Erdine S, Farsang C, Gaita D, Kiowski W, Lip G, Mallion JM, Manolis AJ, Nilsson PM, O'Brien E, Ponikowski P, Redon J, Ruschitzka F, Tamargo J, van Zwieten P, Viigimaa M, Waeber B, Williams B, Zamorano JL, The task force for the management of arterial hypertension of the European Society of Hypertension, The task force for the management of arterial hypertension of the European Society of Cardiology (2007) 2007 Guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28:1462–1536
Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Mosca L, Benjamin EJ, Berra K, Bezanson JL, Dolor RJ, Lloyd-Jones DM, Newby LK, Piña IL, Roger VL, Shaw LJ, Zhao D, Beckie TM, Bushnell C, D'Armiento J, Kris-Etherton PM, Fang J, Ganiats TG, Gomes AS, Gracia CR, Haan CK, Jackson EA, Judelson DR, Kelepouris E, Lavie CJ, Moore A, Nussmeier NA, Ofili E, Oparil S, Ouyang P, Pinn VW, Sherif K, Smith SC Jr, Sopko G, Chandra-Strobos N, Urbina EM, Vaccarino V, Wenger NK; American Heart Association (2011) Effectiveness-based guidelines for the prevention of cardiovascular disease in women: 2011 update: a guideline from the American Heart Association. J Am Coll Cardiol 57:1404–1423
Nakajima T, Ota N, Yoshida H, Watanabe T, Emi M (1999) Allelic variants in the interleukin-6 gene and essential hypertension in Japanese women. Genes Immun 1:115–119
Öksüz E (2004) Hipertansiyonda klinik değerlendirme ve ilaç dışı tedavi. Sted 13:103s
Özcan N (1995) Hipertansiyon İdeal Matbaacılık, Ankara
Pola R, Flex A, Gaetani E, Pola P, Bernabei R (2002) 174 G/C polymorphism of the interleukin-6 gene promoter and essential hypertension in an elderly Italian population. J Hum Hypertens 16:637–640
Ridker PM, Rifai N, Stampfer MJ, Hennekens CH (2000) Plasma concentration of IL-6 and the risk of future myocardial infarction among apparently healthy men. Circulation 101:1767–1772
Rivera-Chavez FA, Peters-Hybki DL, Barber RC, O’Keefe GE (2003) Interleukın-6 promoter haplotypes and interleukın-6 cytokine responses. Shock 20:218–223
Sanders J, Hawe E, Brull DJ, Hubbart C, Lowe GDO, Rumley A, Humphries SE, Montgomery HE (2009) Higher IL-6 levels but not IL6 -174G>C or -572G>C genotype areassociated with post-operative complication following coronary artery bypass graft (CABG) surgery. Atherosclerosis 204:196–201
Savoia C, Schiffrin EL (2006) Inflammation in hypertension. Curr Opin Nephrol Hypertens 15:152–158
Sesso HD, Wang L, Buring JE, Ridker PM, Gaziano JM (2006) Comparison of interleukin-6 and c-reactive protein for the risk of developing hypertension in women. Hypertension 49:304–310
Suheil SJ (2007) Risk factors for hypertension among urban males in Mombasa Kenya. Official Publication of the Tanzania Medical Students’ Association 8:13–16
Tabassum N, Ahmad F (2011) Role of natural herbs in the treatment of hypertension. Pharmacogn Rev 5:30–40
Tanaka C, Mannamı T, Kamıde K, Takıuchı S, Kokubo Y, Katsuya T, Kawano Y, Mıyata T, Ogıhara T, Tomoıke H (2005) Single nucleotide polymorphisms in the interleukin gene associated with blood pressure and atherosclerosis in a Japanese general population. Hypertens Res 28:35–41
Timasheva YR, Nasibullin TR, Zakirova AN, Mustafina OE (2008) Association of interleukin-6, interleukin- 12, and interleukin-10 gene polymorphisms with essential hypertension in Tatars from Russia. Biochem Genet 46:64–74
Tonet AC, Karnikowski M, Moraes CF, Gomes L, Karnikowski MGO, Cordova C, Nobrega OT (2008) Association between the -174 G/C promoter polymorphism of the interleukin-6 gene and cardiovascular disease risk factors in Brazilian older women. Braz J Med Biol Res 41:47–53
Wang L, Manson JE, Gaziano JM, Liu S, Cochrane B, Cook NR, Ridker PM, Rifai N, Sesso HD (2011) Circulating inflammatory and endothelial markers and risk of hypertension in white and black postmenopausal women. Clin Chem 57:729–736
Wong LYF, Leung RYH, Ong KL, Cheung BMY (2007) Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572 C4G polymorphism in subjects with and without hypertension. J Hum Hypertens 21:875–882
Wypasek E, Undas A, Maciejewska MS, Kapelak B, Plicner D, Stepien E, Sadowski J (2010) The increased plasma C-reactive protein and interleukin-6 levels in patients undergoing coronary artery bypass grafting surgery are associated with the interleukin-6 -174G>C gene polymorphism. Ann Clin Biochem 47:343–349
Yamada Y, Matsuo H, Segawa T, Watanabe S, Kato K, Hibino T, Yokoi K, Ichihara S, Metoki N, Yoshida H, Satoh K, Nozawa Y (2006) Assessment of the genetic component of hypertension. Am J Hypertens 19:1158–1165
Acknowledgments
This study was supported by a grant of the Research Foundation of Adıyaman University (FEFYL/2012-0002), Turkey.
Conflict of interest
The authors declare that there is no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Karaman, E., Urhan Kucuk, M., Bayramoglu, A. et al. Investigation of relationship between IL-6 gene variants and hypertension in Turkish population. Cytotechnology 67, 947–954 (2015). https://doi.org/10.1007/s10616-014-9732-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10616-014-9732-1